BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

975 related articles for article (PubMed ID: 6186264)

  • 1. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A; García JC; Fernández R; Fernández Cartaya L
    Bol Estud Med Biol; 1993; 41(1-4):13-9. PubMed ID: 7521168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
    Poceta JS; Parsons L; Engelland S; Kripke DF
    Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ; Bird ED; McEntee WJ
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamines in the brain cerebrospinal fluid of facial pain patients.
    Bouckoms AJ; Sweet WH; Poletti C; Lavori P; Carr D; Matson W; Gamache P; Aronin N
    Anesth Prog; 1992; 39(6):201-8. PubMed ID: 7504420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects.
    Eklundh T; Eriksson M; Sjöberg S; Nordin C
    J Psychiatr Res; 1996; 30(3):201-8. PubMed ID: 8884658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Age changes in concentrations of monoamines and related substances in the cerebrospinal fluid].
    Takahashi S; Abe T
    No To Shinkei; 1991 Apr; 43(4):331-6. PubMed ID: 1716119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
    Kay AD; Schapiro MB; Riker AK; Haxby JV; Rapoport SI; Cutler NR
    Ann Neurol; 1987 Apr; 21(4):408-11. PubMed ID: 2437853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid kynurenic acid in male and female controls - correlation with monoamine metabolites and influences of confounding factors.
    Nilsson LK; Nordin C; Jönsson EG; Engberg G; Linderholm KR; Erhardt S
    J Psychiatr Res; 2007; 41(1-2):144-51. PubMed ID: 16434056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ; Lu XF; Wang KJ; Ou YS; Huang YQ
    Chin Med J (Engl); 1989 Jan; 102(1):18-23. PubMed ID: 2475306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of idebenone on monoamine metabolites in the cerebrospinal fluid of patients with cerebrovascular dementia].
    Kawakami M; Itoh T
    No To Shinkei; 1986 Feb; 38(2):187-93. PubMed ID: 2421750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rostrocaudal gradient for neurotransmitter metabolites and a caudorostral gradient for protein in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Whitmer B; Satjawatcharaphong C
    Am J Vet Res; 1988 Dec; 49(12):2134-7. PubMed ID: 2467594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous determination of DOPAC, MHPG, 5-HIAA and HVA in CSF by direct injection on a liquid chromatograph with coulometric detection.
    d'Eril GV; Rizzo V; Cellerino GP
    Funct Neurol; 1990; 5(2):145-9. PubMed ID: 1699850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
    Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient.
    Janssens J; Atmosoerodjo SD; Vermeiren Y; Absalom AR; den Daas I; De Deyn PP
    Neurochem Int; 2019 Sep; 128():154-162. PubMed ID: 31034914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The changes of monoamine metabolites in CSF of patients with cerebral stroke].
    Tang HZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):130-2, 186. PubMed ID: 1716195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.